Product custom-nanocomposites-nanopeptides

Home > products > custom-nanocomposites> nanopeptides

Catalog	name	Description	price
R-M2-10835	Liposome@Pemafibrate (K-877) and surface peptide targeting peg2k-PECAM-1 (CD31)	Liposome@Pemafibrate (K-877) and surface peptide targeting peg2k-PECAM-1 (CD31)/Liposome loaded Pemafibrate (K-877)+surface peptide targeting peg2k-PECAM-1 (CD31) is a specific targeted peptide PECAM-1 (CD31) loaded pembrolizumab (K-877) long circulating liposome nanomaterial, which belongs to the forefront of targeted delivery for cardiovascular diseases. Currently, it is only in the laboratory research stage and has no clinical products on the market. It can be used in the research of targeted treatment of atherosclerosis, vascular endothelial injury related diseases, and drug delivery system optimization.	price>
R-M2-10922	SP94 peptide-liposomes@capsaicin	SP94 peptide-liposomes@capsaicin/SP94 peptide modified liposomes encapsulating capsaicin is a functional nano drug delivery system developed specifically for targeted therapy of liver cancer. It uses SP94 liver cancer specific targeting peptide modified liposomes as carriers to efficiently encapsulate the hydrophobic active ingredient capsaicin, greatly improving the tumor targeting enrichment efficiency and in vivo bioavailability of the drug.	price>
R-M2-10931	Chitosan(20-50nm) nanoparticles@Catalpol surface targets peptide TGNYKALHPHNG	Chitosan(20-50nm)nanoparticles@Catalpol surface targets peptide TGNYKALHPHNG/Chitosan(20-50nm) nanoparticles loaded Catalpol surface targets peptide TGNYKALHPHNG is a functionalized chitosan nanocarrier system developed specifically for targeted delivery of central nervous system diseases. It uses narrow distribution chitosan nanoparticles at 20-50 nm as carriers, efficiently encapsulating the neuroprotective active ingredient catalpol, and surface anchoring TGNYKALHPHNG cross blood-brain barrier targeting peptides to achieve precise and efficient delivery of catalpol to brain lesions.	price>

...